A5031112719- Pelvic floor disorders treatments
- Urinary Bladder and Prostate Research
- Anorectal Disease Treatments and Outcomes
- Ureteral procedures and complications
- Diverticular Disease and Complications
- Urinary Tract Infections Management
- Urological Disorders and Treatments
- Psychosomatic Disorders and Their Treatments
- Hernia repair and management
- Botulinum Toxin and Related Neurological Disorders
- Female Genital Mutilation/Cutting Issues
- Long-Term Effects of COVID-19
- Pediatric Urology and Nephrology Studies
- Vagus Nerve Stimulation Research
- Acupuncture Treatment Research Studies
Rush University
2020-2024
Rush University Medical Center
2018-2024
Seattle University
2017
Virginia Mason Medical Center
2016-2017
Seattle Reproductive Medicine
2017
New York University
2015
American Urological Association
2015
Overactive bladder impacts more than 15% of the adult population. Compliance with medical treatment is low due to inadequate symptom control or intolerable side effects. Although third line therapies have improved overactive bladder, many patients do not receive optimal treatment. We hypothesized that use higher among female pelvic medicine and reconstructive surgery urologists, we examined its at our tertiary referral center.The electronic record was queried for seen in 1 year. The number...
Abstract Aims To evaluate factors associated with progression to stage 2 sacral neuromodulation (SNM) for refractory overactive bladder, urinary retention, or fecal incontinence using optimal lead placement techniques curved stylet. Methods This is a retrospective analysis of prospectively collected database all consecutive 1 SNM placements at our institution between August 2014 and May 2017 technique Patients were enrolled. 50% more symptom improvement on voiding diaries offered implant....
Purpose To identify demographic and clinical characteristics of patients with symptomatic pelvic floor mesh complications who underwent removal at our academic medical center. The secondary goal was to determine patient-reported outcomes after removal. Materials methods We conducted a retrospective review consecutive from 2011-2016 undergoing graft for treatment mesh-related complications. Patient demographics, comorbidities, symptoms, factors were evaluated. Outcomes explant determined by...
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Female Incontinence (MP23)1 May 2024MP23-20 THERE IS NO ASSOCIATION BETWEEN URINARY TRACT INFECTIONS AND FECAL INCONTINENCE IN AN AMBULATORY ADULT PATIENT POPULATION Sabrina L. Stair, Jamie Yoon, Kyle Dymanus, Una Lee, and Sarah Adelstein StairSabrina Stair , YoonJamie Yoon DymanusKyle Dymanus LeeUna Lee AdelsteinSarah View All Author...
You have accessJournal of UrologyBenign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy (MP09)1 May 2024MP09-05 POSTOPERATIVE URINARY INCONTINENCE FOLLOWING BPH SURGERY: INSIGHTS FROM A COMPREHENSIVE U.S. DATABASE ANALYSIS Leslie Claire Licari, Celeste Manfredi, Eugenio Bologna, Antonio Franco, Francesco Ditonno, Morgan Sturgis, Spencer Mossack, Cosimo De Nunzio, Alessandro Antonelli, Giuseppe Simone, Marco Sio, Christopher Coogan, Sarah A. Adelstein, Edward E....
Urinary tract infections (UTIs) are a leading cause of infection in adults. The most common is gastrointestinal bacteria ascending the urethra into bladder. Studies showing fecal incontinence (FI) risk factor for UTI have been limited to nursing home populations. Healthy patients with recurrent UTI, especially women, often receive counseling, suggesting improper personal hygiene contributes UTIs. This advice can be stigmatizing. Given prevalence, it important elucidate factors improved...
Postoperative urinary incontinence (UI) is a feared complication of BPH surgery. Our study aims to investigate the incidence UI among patients undergoing different procedures for BPH.
Sacral neuromodulation (SNM) is an effective third-line therapy for overactive bladder (OAB). COVID-19 may have a temporary negative effect on SNM function. We describe two cases of increased sensory thresholds and loss efficacy following infection. In both these cases, efficacy, thresholds, impedances were spontaneously restored after few months without surgical intervention. Withholding revision due to transient post-COVID-19-induced impairment be appropriate; however, further research...
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Female Incontinence: Therapy I1 Apr 2017MP40-15 USE OF THIRD LINE THERAPY FOR OVERACTIVE BLADDER IN A PRACTICE WITH MULTIPLE SUBSPECIALTY PROVIDERS: ARE WE DOING ENOUGH? Dena Moskowitz, Sarah Adelstein, Alvaro Lucioni, Una Lee, and Kathleen Kobashi MoskowitzDena Moskowitz More articles by this author , AdelsteinSarah Adelstein LucioniAlvaro Lucioni LeeUna Lee KobashiKathleen View All Author...
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Prolapse II1 Apr 2017PD17-09 FIVE-YEAR EXPERIENCE WITH PELVIC FLOOR MESH EXPLANT SURGERY: PATIENT CHARACTERISTICS AND REPORTED OUTCOMES Elliot Blau, Sarah Adelstein, Alvaro Lucioni, Kathleen Kobashi, and Una Lee BlauElliot Blau More articles by this author , AdelsteinSarah Adelstein LucioniAlvaro Lucioni KobashiKathleen Kobashi LeeUna View All Author...
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Female Incontinence: Therapy III1 Apr 2017PD54-03 OPTIMIZING LEAD PLACEMENT DURING STAGED SACRAL NEUROMODULATION (SNM): FACTORS ASSOCIATED WITH PROGRESSION TO STAGE 2 Sarah A Adelstein, Kevin Gioia, Jonathan Wingate, Alvaro Lucioni, Kathleen C Kobashi, and Una J Lee AdelsteinSarah Adelstein More articles by this author , GioiaKevin Gioia WingateJonathan Wingate LucioniAlvaro Lucioni...
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Prolapse I1 Apr 2017PD02-04 PRACTICE PATTERNS IN THE DIAGNOSIS AND TREATMENT OF FECAL INCONTINENCE WITH SACRAL NEUROMODULATION: CAN UROLOGISTS IMPACT THIS GAP CARE? Dena Moskowitz, Sarah Adelstein, Alvaro Lucioni, Kathleen Kobashi, and Una Lee MoskowitzDena Moskowitz More articles by this author , AdelsteinSarah Adelstein LucioniAlvaro Lucioni KobashiKathleen Kobashi LeeUna View All Author...
The prevalence of fecal incontinence (FI) is 8% in the United States. Many patients will not seek treatment and condition underdiagnosed. Sacral neuromodulation (SNM) effective treating FI, so urologists can play a key role its treatment. We examine practice patterns FI with SNM our institution.The electronic medical record was queried for proportion seen institution, urology department, among female pelvic medicine reconstructive surgery (FPMRS) urologists. who underwent were evaluated...
No consensus exists on outcomes that define high quality care in female stress urinary incontinence management. A working group of surgeons from diverse health settings Washington State who treat was convened through a state level collaborative. Preliminary questions were developed and focus groups conducted to obtain surgeon input perspectives surgery measures guide future research.Washington perform sling recruited via email. Focus teleconference using preliminary as discussion points....
You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Neurogenic Voiding Dysfunction (PD36)1 Sep 2021PD36-08 HIGH-DOSE ONABOTULINUMTOXIN A FOR MULTIPLE INDICATIONS IN THE NEUROUROLOGY PATIENT Robert Esterquest, Jamaal Jackson, Kevin Alter, Andrew Patton, Ravi Kasi, and Sarah Adelstein EsterquestRobert Esterquest More articles by this author , JacksonJamaal Jackson AlterKevin Alter PattonAndrew Patton KasiRavi Kasi AdelsteinSarah View All Author...